FINWIRES · TerminalLIVE
FINWIRES

$AXGN

9 stories mentioning AXGNUpdated 3d ago

Every FINWIRES story that references AXGN, newest first.

What are analysts saying about AXGN?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on AXGN?

Commodities

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.6%, and the actively traded Invesco QQQ Trust (QQQ) was 1.5% lower in Thursday's premarket activity amid the release of producer-price inflation data.US stock futures were mixed, with S&P 500 Index futures down 0.1%, Dow Jones Industrial Average futures gaining 0.1%, and Nasdaq futures slipping 0.6% before the start of regular trading.The US Producer Price Index rose 0.4% in August, as expected in a survey compiled by Bloomberg, following a 0.1% gain in July.Initial jobless claims fell to 206,000 in the week ended Sept. 5 from 207,000 in the previous week, compared with expectations for a drop to 205,000.The existing home sales report for August and wholesale inventory data for July will be released at 10 am ET.Weekly natural gas stocks will be released at 10:30 am ET.In premarket activity, bitcoin was down by 0.6%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 0.7% lower, Ether ETF (EETH) retreated 0.1%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was flat.Power Play:TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) retreated 1%, the iShares US Technology ETF (IYW) was 0.4% lower, and the iShares Expanded Tech Sector ETF (IGM) was inactive. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) was inactive, while the iShares Semiconductor ETF (SOXX) fell 2.1%.Navan (NAVN) shares were down 15% following the company's fiscal Q2 results and acquisition of events platform BoomPop.Winners and Losers:FinancialThe State Street Financial Select Sector SPDR ETF (XLF) was flat. Direxion Daily Financial Bull 3X Shares (FAS) was up 0.9%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 1% lower.Hagerty (HGTY) shares were down 8% in early-hours activity after the company priced an upsized secondary offering by a selling shareholder of about 9.3 million Class A common shares at $11.95 apiece.EnergyThe iShares US Energy ETF (IYE) was inactive, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 1.3%.Centrus Energy (LEU) stock was down more than 7%, a day after the company priced a public offering of its securities for expected gross proceeds of about $500 million.Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) advanced 0.3%, the Vanguard Health Care Index Fund (VHT) was up 0.1%, while the iShares US Healthcare ETF (IYH) was inactive. The iShares Biotechnology ETF (IBB) retreated 0.2%.Axogen (AXGN) stock was down more than 4% premarket after the company said it has agreed to acquire privately held medical device company BioCircuit Technologies and priced a $208.7 million public offering of about 4.9 million shares.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.4%, while the Vanguard Consumer Staples Index Fund ETF Shares (VDC) and the iShares US Consumer Staples ETF (IYK) were inactive. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) gained 0.3%. The VanEck Retail ETF (RTH) was down 0.4%, while the State Street SPDR S&P Retail ETF (XRT) was 0.3% lower.Macy's (M) shares were down more than 4% pre-bell after the company said it expects an adjusted loss for fiscal Q3.IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) was flat, while the Vanguard Industrials Index Fund (VIS) and the iShares US Industrials ETF (IYJ) were inactive.SpaceX (SPCX) shares were retreating marginally by 0.6% before the opening bell. Reuters reported Thursday, citing disclosures it received in response to a freedom of information request, that the company has received about $40 million from the UK government in exchange for its satellite services.CommoditiesFront-month US West Texas Intermediate crude oil was up by 3.8% at $99.65 per barrel on the New York Mercantile Exchange. Natural gas was 1.2% lower at $2.79 per 1 million British Thermal Units. The United States Oil Fund (USO) rose 2.7%, while the United States Natural Gas Fund (UNG) retreated 1.1%.Gold futures for November were down by 1.3% at $4,404.60 an ounce on the Comex. Silver futures fell 4.4% to $65.63 an ounce. SPDR Gold Shares (GLD) decreased 1.6%, and the iShares Silver Trust (SLV) was 4.9% lower.

Dow JonesNasdaq CompositeS&P 500$AXGN$FAS$FAZ$GLD$HGTY$IBB$IGM$IYE$IYH$IYJ$IYK$IYW$LEU$M$NAVN$QQQ$RTH$SLV$SOXX$SPCX$SPY$UNG$USO$VDC$VHT$VIS$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Sectors

Sector Update: Healthcare Stocks Mixed Pre-Bell Thursday

Healthcare stocks were mixed pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.4% and the iShares Biotechnology ETF (IBB) 0.5% lower.Cooper (COO) shares were down more than 17% after the company cut its fiscal 2026 guidance.Novartis (NVS) shareholder Artisan Partners called for changes to the Swiss drugmaker's board following two consecutive drug trial setbacks that sent shares tumbling, Reuters reported, citing an interview with Artisan managing director David Samra. Novartis stock was up more than 1% premarket.Axogen (AXGN) shares were down more than 4% after the company said it has priced an underwritten public offering of about 4.9 million shares at $42.50 each, with gross proceeds expected to be about $208.7 million.

$AXGN$COO$IBB$NVS$XLV
Research

Truist Securities Initiates Axogen at Buy With $60 Price Target

Axogen (AXGN) has an average rating of buy and mean price target of $53.90, according to analysts polled by FactSet.

$AXGN
Insider Trading

Axogen Insider Sold Shares Worth $646,592, According to a Recent SEC Filing

Amy McBride Wendell, Director, on August 11, 2026, sold 13,353 shares in Axogen (AXGN) for $646,592. Following the Form 4 filing with the SEC, Wendell has control over a total of 107,976 common shares of the company, with 107,976 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/805928/000080592826000098/xslF345X05/wk-form4_1786565567.xml

$AXGN
Insider Trading

Axogen Insider Sold Shares Worth $3,195,788, According to a Recent SEC Filing

Marc A Began, Executive Vice President & General Counsel, on August 10, 2026, sold 67,500 shares in Axogen (AXGN) for $3,195,788. Following the Form 4 filing with the SEC, Began has control over a total of 50,135 common shares of the company, with 50,135 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/805928/000080592826000099/xslF345X05/wk-form4_1786565598.xml

$AXGN
Sectors

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Health care stocks edged up late Tuesday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2%.The iShares Biotechnology ETF (IBB) declined 0.6%.In sector news, the US Food and Drug Administration plans to pilot an approach this summer that will use AI to accelerate clinical trials of new medicines by automating data collection and submission, The Wall Street Journal reported Tuesday, citing an interview with Jeremy Walsh, the FDA's chief AI officer.In corporate news, Axogen (AXGN) shares jumped past 6% after it reported Tuesday a swing to Q1 adjusted EPS from a a loss a year earlier following a surge in revenue.Pfizer (PFE) said Tuesday it entered into settlement agreements with three generic drug manufacturers regarding lawsuits filed in the US District Court for the District of Delaware for patent infringement related to Vyndamax, a cardiomyopathy transthyretin-mediated amyloidosis treatment. Pfizer shares were down 1.7%.Eli Lilly (LLY) has entered into a strategic partnership with Profluent to develop AI-designed recombinases for genetic medicines, Profluent said Tuesday. Lilly shares rose 0.6%.Novartis (NVS) reported Q1 core earnings Tuesday of $1.99 per share, down from $2.28 a year earlier. Analysts polled by FactSet expected $2.19. Net sales for the quarter ended March 31 were $13.11 billion, down from $13.23 billion a year earlier. For 2026, the company said it continues to expect a low-single-digit core operating income decline. Novartis shares were up 0.3%.

$AXGN$LLY$NVS$PFE
Sectors

Sector Update: Health Care

Health care stocks edged up late Tuesday afternoon, with the NYSE Health Care Index fractionally higher and the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2%.The iShares Biotechnology ETF (IBB) declined 0.6%.In corporate news, Axogen (AXGN) shares jumped past 6% after it reported Tuesday a swing to Q1 adjusted EPS from a a loss a year earlier following a surge in revenue.

$AXGN
Wire

Top Midday Gainers

Sanmina (SANM) reported late Monday fiscal Q2 adjusted earnings and revenue above market expectations, with sales more than doubling.Shares climbed 13% as intraday trading volume jumped to over 2.20 million from a daily average of about 779,000.Kforce (KFRC) reported late Monday better-than-expected Q1 results, with its Q2 guidance for earnings and revenue also exceeding market expectations.Shares surged 45%, with intraday trading volume of over 945,000 against a daily average of roughly 282,000.Axogen (AXGN) shares jumped 7% after the company reported Tuesday a swing to Q1 adjusted EPS from a a loss a year earlier following a surge in revenue.More than 1.75 million shares traded intraday, compared with a daily average of about 1.03 million.Price: $212.30, Change: $+24.22, Percent Change: +12.88%

$AXGN$KFRC$SANM
Sectors

Sector Update: Health Care Stocks Mixed Pre-Bell Tuesday

Health care stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) gaining by 0.6% and the iShares Biotechnology ETF (IBB) retreating marginally by 0.01%.Novartis (NVS) shares retreated less than 1% pre-bell after the company reported lower Q1 core earnings and net sales.Axogen (AXGN) stock was up more than 9% premarket after the company reported it swung to Q1 adjusted earnings as revenue increased.Zimmer Biomet (ZBH) stock was down more than 6% premarket after closing the prior session with a 1.5% gain. The company reported higher Q1 financial results and said its chief financial officer, Suketu Upadhyay, is leaving the company.

$AXGN$IBB$NVS$XLV$ZBH

Track with the FINWIRES app suite